Drug: Latest News, Top Stories & Analysis

Melior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics

August 2, 2021August 1, 2021 - by MyChesCo

EXTON, PA — Melior Pharmaceuticals announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . (OTCPK: ATRX) for Melior’s Parkinson’s disease (PD) candidate, MLR-1019 (armesocarb).

Government / National

Federal Trade Commission Sends Report to Congress on Rebate Walls

June 1, 2021May 29, 2021 - by MyChesCo

WASHINGTON, D.C. — The Federal Trade Commission recently sent a report to Congress about the effects that so-called rebate walls have on competition in markets for pharmaceutical and biopharmaceutical drugs.